Proteomic and Metabolomic Lacrimal Fingerprint in Diverse Pathologies of the Ocular Surface
NCT04198740 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2026-04-27
Summary
This study aims to obtain the lacrimal fingerprint for frequent pathologies of the ocular surface and establish a normative base for each of them.
Conditions
- Dry Eye Syndrome
- Infectious Keratoconjunctivitis
- Mucous Membrane Pemphigoid
- Allergic Conjunctivitis
Interventions
- DIAGNOSTIC_TEST
-
Tear sample collection via Schirmer strip and subsequent analysis by mass spectrometry
During regular consultations at the ophthalmology department of the CHUM, eligible patients will undergo a standard 5 minute Schirmer tear test. The Schirmer strips will serve as tear samples and will be sent to UQAM's Department of chemistry for mass spectrometry analysis.
Sponsors & Collaborators
-
Université du Québec a Montréal
collaborator OTHER -
Centre hospitalier de l'Université de Montréal (CHUM)
lead OTHER
Principal Investigators
-
Marie-Claude Robert, MD, M.Sc · Centre hospitalier de l'Université de Montréal (CHUM)
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-02-01
- Primary Completion
- 2034-10-31
- Completion
- 2035-01-31
Countries
- Canada
Study Locations
More Related Trials
-
Diagnostic Evaluation of the Tear Film
NCT00761917 ·Status: COMPLETED
-
CXCL9, CXCL10, CXCL11, and CXCR3 in Dry Eye Syndrome
NCT00991679 ·Status: COMPLETED
-
Ocular Surface Microbiome in Dry Eye Patients
NCT02161341 ·Status: COMPLETED
-
Ocular Surface Dry Eye Microbiome
NCT02306668 ·Status: UNKNOWN
-
Tear Film SARS-nCoV-2 Detection in Symptomatic and Pauci-symptomatic Patients.
NCT04799704 ·Status: TERMINATED
-
A Study To Investigate The Effects Of A Low Humidity Environment And Visual Tasking On Tear Film Protein Composition
NCT02005874 ·Status: COMPLETED
-
The Ocular Microbiome in Patients With Dry Eye Disease
NCT04656197 ·Status: COMPLETED
-
Efficacy of the Chronic Application of Tear Formulations
NCT01384851 ·Status: UNKNOWN ·Phase: NA
-
Assessment of Inflammatory and Functional Changes in the Ocular Surface Associated With Dry Eye Disease
NCT00809003 ·Status: COMPLETED
-
Comparing the Quality of Topical Autologous Serum in Different Etiologies of Dry Eye Syndrome
NCT02774707 ·Status: UNKNOWN
-
Ocular Surface Disease in Chronic Graft-Versus-Host Disease (GVHD) Patients
NCT02712762 ·Status: COMPLETED
-
Confocal Microscopy and Lacrimal Gland in Sjogren's Syndrome
NCT00920179 ·Status: UNKNOWN
-
Detecting SARS-CoV-2 in Tears
NCT04526769 ·Status: COMPLETED
-
Evaluation of Lacrimal Punctal Changes by Anterior Segment Optical Coherence Tomography AS-OCT After Topical Combined Antibiotics and Steroids Treatment in Cases of Inflammatory Punctual Stenosis
NCT05028907 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Mucin Levels at the Ocular Surface of Visual Display Users With and Without Dry Eye Disease
NCT05604651 ·Status: COMPLETED
-
Three-dimensional Analysis of EMMPRIN on Conjunctival Epithelial Cells Surface in Severe Dry Eye Syndrome (ALTESSE)
NCT03358979 ·Status: RECRUITING
-
Point of Care Testing of Inflammatory Markers in Tears
NCT02315079 ·Status: COMPLETED
-
Clinical Evaluation of the InflammaDry Device for Detecting Dry Eye
NCT01692964 ·Status: COMPLETED
-
Metabolites of Tear Fluid
NCT03389282 ·Status: UNKNOWN
-
Mucin Levels in Dry Eye and Normal Populations
NCT05911555 ·Status: COMPLETED
-
Evaluation of FID 114657 in Sjogren's Syndrome Subjects
NCT01079871 ·Status: COMPLETED ·Phase: NA
-
Effects of Carboxymethylcellulose Artificial Tears on the Eye Microbiome
NCT05292755 ·Status: COMPLETED ·Phase: PHASE4
-
Ocular Surface Immune Response in Dry Eye Disease
NCT02042820 ·Status: COMPLETED
-
Proteomics Analysis of Human Tears in the Diagnosis and Management of Dry Eye Disease
NCT07175909 ·Status: RECRUITING ·Phase: NA
-
Microbiological Diagnosis of Infectious Keratitis to Pathogenic Fastidious Germs
NCT02819232 ·Status: COMPLETED ·Phase: NA